Company news
Propanc Biopharma, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Propanc Biopharma Appoints Belen Toledo to Evaluate Impact of Proenzyme Therapy on Tumor Microenvironment
January 27, 2021
Propanc Biopharma Receives Expression of Interest to Evaluate Proenzyme Therapy in Pancreatic and Ovarian Cancer Patients
January 17, 2021
Propanc Biopharma Analyzes Pancreatic Proenzymes Vs T-Cell Therapy Targeting Solid Tumors Such as Pancreatic, Ovarian & Colorectal Cancers
January 10, 2021
Propanc Biopharma Receives First Granted Patent for Method to Treat Cancer Stem Cells from Australian Patent Office
December 20, 2020
Propanc Biopharma Receives Investment from Institutional Investor
July 27, 2020
How Propanc Biopharma Is Joining the Fight with Cancer Patients Who Are Increasingly Vulnerable to the COVID-19 Global Pandemic
April 15, 2020
Propanc Biopharma Receives First Allowance for Key Patent Family from Australian Patent Office
April 13, 2020
Propanc Biopharma Enters Into a $3 Million Financing with Institutional Investor
March 30, 2020
Propanc Biopharma’s Scientific Advisory Board Member Promoted to Professorship Position at Jaén University, Spain
March 15, 2020
Propanc Biopharma Receives Advance Overseas Finding from Innovation and Science Australia
January 20, 2020
Propanc Biopharma Advances POP1 Drug Discovery Program
November 17, 2019
Decks
- Investor Presentation (April 2024)
Investor deck · 26 slides · Apr 10, 2024
- Investor Presentation (February 2019)
Investor deck · 25 slides · Feb 12, 2019
- Investor Presentation (September 2018)
Investor deck · 32 slides · Sep 7, 2018
- Investor Presentation (June 2017)
Investor deck · 38 slides · Jun 1, 2017
- Investor Presentation
Investor deck · 29 slides